RETRACTABLE TECHNOLOGIES INCRVPEarnings & Financial Report
Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.
Revenue
$10.4M
Gross Profit
$-107.1K
Operating Profit
$-5.1M
Net Profit
$-87.5K
Gross Margin
-1.0%
Operating Margin
-49.1%
Net Margin
-0.8%
YoY Growth
73.2%
EPS
$0.00
RETRACTABLE TECHNOLOGIES INC Q2 FY2025 Financial Summary
RETRACTABLE TECHNOLOGIES INC reported revenue of $10.4M (up 73.2% YoY) for Q2 FY2025, with a net profit of $-87.5K (up 99.4% YoY) (-0.8% margin). Cost of goods sold was $10.6M, operating expenses totaled $5.0M.
Key Financial Metrics
| Total Revenue | $10.4M |
|---|---|
| Net Profit | $-87.5K |
| Gross Margin | -1.0% |
| Operating Margin | -49.1% |
| Report Period | Q2 FY2025 |
RETRACTABLE TECHNOLOGIES INC Annual Revenue by Year
RETRACTABLE TECHNOLOGIES INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $38.3M).
| Year | Annual Revenue |
|---|---|
| 2025 | $38.3M |
| 2024 | $33.0M |
| 2023 | $43.6M |
| 2022 | $94.8M |
RETRACTABLE TECHNOLOGIES INC Quarterly Revenue & Net Profit History
RETRACTABLE TECHNOLOGIES INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $9.4M | +4.0% | $-2.3M | -24.9% |
| Q3 FY2025 | $10.1M | -2.5% | $371.0K | 3.7% |
| Q2 FY2025 | $10.4M | +73.2% | $-87.5K | -0.8% |
| Q1 FY2025 | $8.3M | +9.2% | $-10.5M | -126.6% |
| Q4 FY2024 | $9.1M | -36.5% | $3.8M | 41.6% |
| Q3 FY2024 | $10.3M | +0.1% | $-1.9M | -18.6% |
| Q2 FY2024 | $6.0M | -24.4% | $-14.2M | -234.9% |
| Q1 FY2024 | $7.6M | -30.9% | $429.4K | 5.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.6M | $6.0M | $10.3M | $9.1M | $8.3M | $10.4M | $10.1M | $9.4M |
| YoY Growth | -30.9% | -24.4% | 0.1% | -36.5% | 9.2% | 73.2% | -2.5% | 4.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $176.0M | $160.7M | $157.8M | $160.7M | $149.3M | $147.1M | $146.4M | $142.6M |
| Liabilities | $76.3M | $75.3M | $74.4M | $73.6M | $72.7M | $70.6M | $69.7M | $68.3M |
| Equity | $99.7M | $85.4M | $83.5M | $87.2M | $76.6M | $76.5M | $76.8M | $74.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.0M | $-2.7M | $-5.7M | $-1.1M | $-1.5M | $-3.7M | $-1.3M | $-596542 |